|
Variables
|
Groups
|
N
|
Percentages
|
|---|
|
Stage
|
1
|
47
|
21.4
|
|
2
|
102
|
46.4
|
|
3
|
57
|
25.9
|
|
Not available
|
14
|
6.3
|
|
Grade
|
1
|
29
|
13.2
|
|
2
|
80
|
36.4
|
|
3
|
98
|
44.5
|
|
Not available
|
13
|
5.9
|
|
Laterality
|
Right side
|
110
|
50
|
|
Left side
|
109
|
49.5
|
|
Bilateral
|
1
|
0.5
|
|
T
|
1
|
74
|
33.6
|
|
2
|
97
|
44.1
|
|
3
|
37
|
16.8
|
|
Not available
|
12
|
5.5
|
|
N
|
0
|
92
|
41.8
|
|
1
|
82
|
37.3
|
|
2
|
23
|
10.4
|
|
3
|
18
|
8.2
|
|
Not available
|
5
|
2.3
|
|
M
|
0
|
220
|
100
|
|
aER
|
Negative
|
60
|
27.3
|
|
Positive
|
158
|
71.8
|
|
Not available
|
2
|
0.9
|
|
bPR
|
Negative
|
78
|
35.5
|
|
Positive
|
140
|
63.6
|
|
Not available
|
2
|
0.9
|
|
cHER-2
|
Negative
|
118
|
53.6
|
|
Equivocal
|
67
|
30.5
|
|
Overexpressed
|
52
|
23.6
|
|
Not available
|
3
|
1.36
|
|
Previous hormone therapy (PHT)
|
No PHT
|
131
|
59.6
|
|
Has had PHT
|
43
|
19.5
|
|
Not available
|
46
|
20.9
|
|
Menopausal status
|
Premenopausal
|
90
|
40.9
|
|
Postmenopausal
|
109
|
49.5
|
|
Not available
|
21
|
9.6
|
- aER: Estrogen Receptor Status. bPR: Progesterone Receptor Status. cHER2: HER-2 Receptor Status.
